Mesothelioma mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from mesothelioma, 2015-2017, UK.

Proportion of all deaths

Percentage mesothelioma contributes to total cancer deaths, 2015-2017, UK

 

Age

Peak rate of mesothelioma deaths, 2015-2017, UK

 

Trend over time

Mesothelioma mortality rates have increased by 887% since the early 1970s, GB

Mesothelioma is the 18th most common cause of cancer death in the UK, accounting for 1% of all cancer deaths (2017).[1-3]

In females in the UK, mesothelioma is not among the 20 most common causes of cancer death (less than 1% of all female cancer deaths). In males in the UK it is the 15th most common cause of cancer death (2% of all male cancer deaths).

17% of mesothelioma deaths in the UK are in females, and 83% are in males.

Mesothelioma mortality rates (European age-standardised (AS) rates) Open a glossary item for persons are significantly lower than the UK average in Northern Ireland and Scotland, and similar to the UK average in all other UK constituent countries.

Mesothelioma (C45), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Deaths 358 22 34 6 420
Crude Rate 1.3 0.8 2.1 0.6 1.3
AS Rate 1.3 0.8 1.9 0.7 1.3
AS Rate - 95% LCL 1.1 0.5 1.3 0.1 1.1
AS Rate - 95% UCL 1.4 1.1 2.6 1.3 1.4
Male Deaths 1,776 146 108 34 2,064
Crude Rate 6.5 5.5 7.0 3.7 6.3
AS Rate 7.8 6.7 7.5 4.8 7.6
AS Rate - 95% LCL 7.4 5.6 6.1 3.2 7.3
AS Rate - 95% UCL 8.1 7.8 8.9 6.4 7.9
Persons Deaths 2,134 168 142 40 2,484
Crude Rate 3.8 3.1 4.5 2.1 3.8
AS Rate 4.2 3.3 4.4 2.5 4.1
AS Rate - 95% LCL 4.0 2.8 3.7 1.7 3.9
AS Rate - 95% UCL 4.3 3.8 5.1 3.3 4.2

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item

For mesothelioma, there are mortality differences between countries despite there being no such differences in incidence.

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C45.

Last reviewed:

Mesothelioma mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2015-2017, on average each year almost 6 in 10 (56%) deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for mesothelioma in older people.

Age-specific mortality rates rise steeply from around age 45-49 and drop in the oldest age groups. The highest rates are in the 85 to 89 age group for females and males. Mortality rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 90+,when the age-specific mortality rate is 9.6 times lower in females than in males.

Mesothelioma (C45), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths
  2. Data were provided by ISD Scotland on request, November 2015. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp​
  3. Data were provided by the Northern Ireland Cancer Registry on request, November 2015. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
Last reviewed:

Mesothelioma European age-standardised (AS) mortality rates for males and females combined increased by 858% in Great Britain between 1971-1973 and 2014-2016.[1-2] The increase was larger in males than in females.

For males, mesothelioma AS mortality rates in Great Britain increased by 872% between 1971-1973 and 2014-2016. For females, mesothelioma AS mortality rates in Great Britain increased by 657% between 1971-1973 and 2014-2016.

Over the last decade in Great Britain (between 2004-2006 and 2014-2016), mesothelioma AS mortality rates for males and females combined increased by 8%.[1-2] In males AS mortality rates remained stable, and in females rates increased by 20%.

Mesothelioma (C45), European Age-Standardised Mortality Rates per 100,000 Population, Great Britain, 1971-2016

Trends in mesothelioma mortality correlate with the rise and fall of asbestos exposure in the UK in the 20th century.[3] It is predicted that the number of mesothelioma deaths in Great Britain will peak around 2017-2018 and decline rapidly thereafter.[4]

Mesothelioma mortality rates have increased overall in some broad adult age groups in males in Great Britain since the early 1970s, but have decreased or remained stable in others.[1-2] Rates in 25-49s have decreased by 68%, in 50-59s have remained stable, in 60-69s have increased by 482%, in 70-79s have increased by 1474%, and in 80+s have increased by 2724%.

Mesothelioma (C45), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, Great Britain, 1971-2016

Mesothelioma mortality rates have increased overall in most broad adult age groups in females in Great Britain since the early 1970s, but have remained stable in some.[1-2] Rates in 25-49s have remained stable, in 50-59s have increased by 103%, in 60-69s have increased by 422%, in 70-79s have increased by 1530%, and in 80+s have increased by 1298%.

Mesothelioma (C45), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Females, Great Britain, 1971-2016

References

  1. Health and Safety Executive, Mesothelioma mortality in Great Britain 1968-2016, MESO02-Death certificates for males mentioning mesothelioma by year of death and 5-year age group. July 2018
  2. Health and Safety Executive, Mesothelioma mortality in Great Britain 1968-2016, MESO03-Death certificates for females mentioning mesothelioma by year of death and 5-year age group. July 2018
  3. Health and Safety Executive. Mesothelioma Mortality by Geographical Area: Mesothelioma mortality in Great Britain 1981-2015. HSE; 2017.
  4. Health and Safety Executive. Asbestos related disease: HSE; 2018.
  5. McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond) 2005;55(2):79-87

About this data

Data is for Great Britain, 1971-2016, C45.

Mortality trends over time data are taken from the Health and Safety Executives record of death certificates mentioning mesothelioma [1-2], as it is the most reliable source of information on mesothelioma mortality in past decades.[5]

Last reviewed:

Mesothelioma mortality rates are projected to fall by 46% in the UK between 2014 and 2035, to 3 deaths per 100,000 people by 2035.[1] This includes a larger decrease for males than for females.

For males, mesothelioma European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 49% between 2014 and 2035, to 5 deaths per 100,000 by 2035.[1] For females, rates are projected to fall by 36% between 2014 and 2035, to 1 death per 100,000 by 2035.[1]

Mesothelioma (C45), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

 

It is projected that 2,298 deaths from mesothelioma (1,876 in males, 422 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C45

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between mesothelioma mortality and deprivation for either males or females in England.[1] England-wide data for 2007-2011 show European age-standardised mortality rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Mesothelioma (C45), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient  in mesothelioma mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C45

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.